SCHEMBL10456111

SCHEMBL10456111

Nc1nc(C#CCC2CCN(C(=O)Oc3ccc(Cl)cc3)CC2)nc2c1ncn2[C@@H]1O[C@H](CO)C(O)[C@@H]1O

nearest known ligand 0.69

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.61
▸ ADORA2B P29275 2/20 0.56
▸ ADORA3 P0DMS8 3/20 0.55
▸ ADORA1 P30542 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1244504 1.00 ADORA2A (0.61) ADORA2AADORA2BADORA3ADORA1
SCHEMBL10457883 1.00 ADORA2A (0.61) ADORA2AADORA2BADORA3ADORA1
SCHEMBL12731388 1.00 ADORA2A (0.61) ADORA2AADORA2BADORA3ADORA1
SCHEMBL1245074 0.94 ADORA2A (0.64) ADORA2AADORA2BADORA3ADORA1
SCHEMBL10458873 0.94 ADORA2A (0.64) ADORA2AADORA2BADORA3ADORA1
SCHEMBL13612209 0.94 ADORA2A (0.62) ADORA2AADORA2BADORA3ADORA1
SCHEMBL14393650 0.94 ADORA2A (0.60) ADORA2AADORA2BADORA3ADORA1
SCHEMBL1244389 0.94 ADORA2A (0.62) ADORA2AADORA2BADORA3ADORA1
SCHEMBL1244335 0.94 ADORA2A (0.60) ADORA2AADORA2BADORA3ADORA1
SCHEMBL10456283 0.94 ADORA2A (0.64) ADORA2AADORA2BADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222228-B2 Substituted aryl piperidinylalkynyladenosines as A2AR agonists FOREST LABORATORIES HOLDINGS LIMITED (BM) 2012-07-17 — — US disclosed
US-7888329-B2 Substituted aryl piperidinylalkynyladenosines as A2AR agonists PGXHEALTH, LLC (US) 2011-02-15 — — US disclosed
US-7589076-B2 Substituted aryl piperidinylalkynyladenosines as A2AR agonists PGX HEALTH, LLC (US) 2009-09-15 — — US disclosed
Send feedback